Guardant Health
GH
#1177
Rank
$19.78 B
Marketcap
$149.22
Share price
4.39%
Change (1 day)
193.39%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $2.09 Billion USD

According to Guardant Health 's latest financial reports the company's total liabilities are $2.09 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$2.11 B30.01%
2024-12-31$1.62 B-0.15%
2023-12-31$1.62 B5.03%
2022-12-31$1.54 B-0.62%
2021-12-31$1.55 B70.22%
2020-12-31$0.91 B699.87%
2019-12-31$0.11 B83.41%
2018-12-31$62.45 M81.9%
2017-12-31$34.33 M-6.88%
2016-12-31$36.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Neogen
NEOG
$1.25 B-40.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
$0.84 B-59.91%๐Ÿ‡บ๐Ÿ‡ธ USA